Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease without meaningful therapeutic options beyond the first salvage therapy. Targeting PDAC metabolism through amino acid restriction has emerged as a promising new strategy. with asparaginases. enzymes that deplete plasma glutamine and asparagine. https://classiquesupplyes.shop/product-category/art-gel/